Keywords: Allergan, Botox, Urinary incontinence, USA, FDA

Allergan gets US FDA nod for Botox to treat form of urinary incontinence

Article | 25 August 2011

Print This

There was a boost for US specialty drug firm Allergan (NYSE: AGN) yesterday when the company revealed that it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in